Advanced search
Publication Cover
Leukemia & Lymphoma Volume 17, 1995 - Issue 1-2
Submit an article Journal homepage
16
Views
25
CrossRef citations to date
0
Altmetric
Original Article

Monoclonal Antibody-Purged Bone Marrow Transplantation Therapy for Multiple Myeloma

Michael V. Seiden From the Divisions of Hematologic Malignancies and Biostatistics, Dana-Farber Cancer Institute, Boston, MA, USA; Departments of Medicine and Radiation Therapy, Harvard Medical School, Boston, MA, USA
,
Robert Schlossman From the Divisions of Hematologic Malignancies and Biostatistics, Dana-Farber Cancer Institute, Boston, MA, USA; Departments of Medicine and Radiation Therapy, Harvard Medical School, Boston, MA, USA
,
Janet Andersen From the Divisions of Hematologic Malignancies and Biostatistics, Dana-Farber Cancer Institute, Boston, MA, USA; Departments of Medicine and Radiation Therapy, Harvard Medical School, Boston, MA, USA
,
Andrea Freeman From the Divisions of Hematologic Malignancies and Biostatistics, Dana-Farber Cancer Institute, Boston, MA, USA; Departments of Medicine and Radiation Therapy, Harvard Medical School, Boston, MA, USA
,
Michael Robertson From the Divisions of Hematologic Malignancies and Biostatistics, Dana-Farber Cancer Institute, Boston, MA, USA; Departments of Medicine and Radiation Therapy, Harvard Medical School, Boston, MA, USA
,
Robert Soiffer From the Divisions of Hematologic Malignancies and Biostatistics, Dana-Farber Cancer Institute, Boston, MA, USA; Departments of Medicine and Radiation Therapy, Harvard Medical School, Boston, MA, USA
,
Arnold Freedman From the Divisions of Hematologic Malignancies and Biostatistics, Dana-Farber Cancer Institute, Boston, MA, USA; Departments of Medicine and Radiation Therapy, Harvard Medical School, Boston, MA, USA
,
Peter Mauch From the Divisions of Hematologic Malignancies and Biostatistics, Dana-Farber Cancer Institute, Boston, MA, USA; Departments of Medicine and Radiation Therapy, Harvard Medical School, Boston, MA, USA
,
Jerome Ritz From the Divisions of Hematologic Malignancies and Biostatistics, Dana-Farber Cancer Institute, Boston, MA, USA; Departments of Medicine and Radiation Therapy, Harvard Medical School, Boston, MA, USA
,
Lee Nadler From the Divisions of Hematologic Malignancies and Biostatistics, Dana-Farber Cancer Institute, Boston, MA, USA; Departments of Medicine and Radiation Therapy, Harvard Medical School, Boston, MA, USA
&
Kenneth C. Anderson From the Divisions of Hematologic Malignancies and Biostatistics, Dana-Farber Cancer Institute, Boston, MA, USA; Departments of Medicine and Radiation Therapy, Harvard Medical School, Boston, MA, USA
 show all
Pages 87-93 | Received 04 Jun 1994, Published online: 01 Jul 2009

References

  • Alexanian R., Dimopoulos M. The treatment of multiple myeloma. N. Engl. J. Med. 1994; 330: 484–489
  • Anderson K., Andersen J., Soiffer R., Freedman A., Rabinowe S., Robertson M.J., Spector N., Blake K., Murray C., Freeman A., Coral F., Marcus K., Mauch P., Nadler L., Ritz J. Monoclonal antibody-purged bone marrow transplantation therapy for multiple myeloma. Blood 1993; 82: 2568–2576
  • Attal M., Huguet F., Schlaifer D., Payen C., Laroche M., Foumie B., Mazieres B., Pris J., Laurent G. Intensive combined therapy for previously untreated aggressive myeloma. Blood 1992; 79(5)1130–1136
  • Gahrton G., Tura S., Flesh M., Gratwohl A., Gravett P., Lucarelli G., Mihallet M., Reiffer J., Ringden O., von Lint M., Vemont J., Zwaan F. Allogeneic bone marrow transplantation in multiple myeloma. N. Engl. J. Med. 1991; 325: 1267–1273
  • Cunningham D., Paz-Ares L., Milan S., Powles R., Nicolson M., Hickish T., Selby P., Trelavan J., Viner C., Malpas J., Slevin M., Findlay M., Raymond J., Gore M. High-dose melphalan and autologous bone marrow transplantation as consolidation in previously untreated myeloma. J. Clin. Oncol. 1994; 12: 759–763
  • Harousseau J.L., Milpied N., Laporte J.P., Collombat P., Facon T., Tigaud J.D., Casassus P., Guilhot F., Ifrah N., Gandhour C. Double-intensive therapy in high-risk multiple myeloma. Blood 1992; 79(11): 2827–2833
  • Jagannath S., Barlogie B. Autologous bone marrow transplantation for multiple myeloma. Hematology Oncology Clinics of North America 1992; 6(2)437–449
  • Bensinger W.I., Buckner C.D., Clift R.A., Petersen F.B., Bianco J.A., Singer J.W., Appelbaum F.R., Dalton W., Beatty P., Fefer A., Storb R., Thomas E.D., Hansen J.A. Phase I study of busulfan and cyclophosphamide in preparation for allogeneic marrow transplant for patients with multiple myeloma. J. Clin. Oncol. 1992; 10(9): 1492–1497
  • Cunningham D., Paz-Ares L., Gore M., Malpas J., Hickish T., Nicolson M., Meldrum M., Viner C., Milan S., Selby A., Raymond N., Powles R. High-dose melphalan for multiple myeloma: Long-term follow-up data. J. Clin. Oncol. 1994; 12: 764–768
  • Anderson K., Barut B., Ritz J., Freedman A., Takvorian T., Rabinowe S., Soiffer R., Heflin L., Coral F., Dear K., Mauch P., Nadler L. Monoclonal antibody purged autologous bone marrow transplantation therapy for multiple myeloma. Blood 1991; 77: 712–720
  • Soiffer R., Murray C., Mauch P., Anderson K., Freedman A., Rabinowe S., Takvorian T., Robertson M., Spector N., Gonin R., Miller K., Rudders R., Freeman A., Blake K., Coral F., Nadler L., Ritz J. Prevention of graft-versus-host disease by selective depletion of CD6-positive T lymphocytes from donor bone marrow. J. Clin. Oncol 1992; 10: 1191–1200
  • Durie B., Salmon S. A clinical staging system for multiple myeloma. Cancer 1975; 36: 842–854
  • Anderson K., Park E., Bates M., Leonard R., Hardy R., Schlossman S., Nadler L. Antigens on human plasma cells identified by monoclonal antibodies. J. Immunol. 1983; 130: 1132–1138
  • Nadler L., Stashenko P., Ritz J., Hardy R., Pesando J., Schlossman S. A unique cell surface antigen identifying lymphoid malignancies of B cell origin. J. Clin. Invest. 1981; 67: 134–140
  • Ritz J., Pesando J., Notis-McConarty J., Lazarus H., Schlossman S. A monoclonal antibody to human acute lymphoblastic leukaemia antigen. Nature 1980; 283: 583–585
  • Weiden P.L., Fluornoy N., Thomas E.D., Prentice R., Fefer A., Buckner D., Storb R. Anti-leukemic effects of graft-versus-host disease in human recipients of allogeneic marrow grafts. N. Engl. J. Med. 1979; 300: 1068–1073
  • Goldman J.M., Gale R.P., Horwitz M.M., Biggs J.C., Champlin R.E., Gluckman E., Hoffmann R.G., Jacobsen S.J., Marmont A.M., McGlave P.B., Messner H.A., Rimm A.A., Rozman C., Speck B., Tura S., Weiner R.S., Bortin M.M. Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion. Ann. Int. Med. 1988; 108: 804–814
  • Attal M., Harousseau J.L., Stoppa A.M., Sotto J.J., Fuzibet G., Rossi J.F., Casassus P., Maisonneuve H., Facon T., Ifrah N., Bataille, R., for the IFM. High dose therapy im multiple myeloma: A prospective randomized study of the “Intergroupe Francais Du Myeloma” (IFM). IV International Workshop on Multiple Myeloma, R.A. Kyle. Rochester, Minnesota 1993; 98

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.